icon
icon
icon
icon
$300 Off
$300 Off

News /

Articles /

Claranova's H1 2024-2025 Revenue: A Closer Look at PlanetArt, Avanquest, and myDevices

Marcus LeeTuesday, Feb 11, 2025 12:36 pm ET
5min read


Claranova, a global leader in e-commerce for personalized objects, software publishing, and the Internet of Things (IoT), reported its H1 2024-2025 revenue in a recent press release. The company's strategic roadmap, "One Claranova," aims to create a more integrated group focused on operational excellence and profitability. This article will delve into the revenue performance of Claranova's PlanetArt, Avanquest, and myDevices divisions during the first half of the fiscal year.



PlanetArt: Steady Performance and Synergies
PlanetArt, Claranova's e-commerce division for personalized objects, reported stable revenue of €60m for Q1 2024-2025. The division's performance was driven by the strong performance of its mobile and web-based offerings. Teams are working on improving returns on marketing investments and optimizing the division's costs. The implementation of synergies under the "One Claranova" roadmap will contribute to economies of scale and an acceleration in the division's sales.

PNTG Total Revenue QoQ
Name
Date
Total Revenue QoQ%
The Pennant GroupPNTG
20240331
7.51


Avanquest: Improved Margins and Core Business Focus
Avanquest, Claranova's software publishing subsidiary, reported revenue of €27m for Q1 2024-2025, up 3% like-for-like (-6% at actual exchange rates). The division benefited from the disposal of its non-core activities in Europe, which were adversely affecting its performance. The percentage of core business consisting of the sale of proprietary SaaS solutions accounted for 91% of the division's revenue for the quarter (87% last year), or €25m (+2% on a like-for-like basis). Sales growth in the Security segment offset the slowdown in the PDF and Photo segments. Efforts to reduce operating costs enabled the division to improve margins over the period.

AVNS Total Revenue
Name
Date
Total Revenue(USD)
Avanos MedicalAVNS
2024 Q1
166.10M


myDevices: Strategic Sale and Revenue Decline
In Q1 2024-2025, revenue for myDevices, Claranova's IoT division, was €1.9m, down 12% at constant exchange rates (-13% at actual exchange rates) compared to last year's first quarter. As a reminder, this division provides little synergy with the Group's other activities and is no longer considered strategic. Consequently, Claranova has retained the investment bank Canaccord Genuity to sell this division, with the aim of completing the transaction within the next few months. This strategic move is expected to contribute to the Group's overall profitability and focus on its core businesses.

In conclusion, Claranova's H1 2024-2025 revenue performance reflects the strategic initiatives undertaken by the company to improve the profitability of its core divisions. The disposal of non-core activities in Avanquest, the strong performance of PlanetArt's mobile and web-based offerings, and the planned sale of myDevices have all contributed to the company's overall revenue and profitability. As Claranova continues to execute its "One Claranova" roadmap, investors will be watching closely to see if the company can achieve its medium-term objectives of €575 to €625 million in revenue and a 13% to 15% EBITDA margin by 2027.
Comments

Add a public comment...
Post
User avatar and name identifying the post author
Excellent-Win-4625
02/11
$TSLA and $AAPL have been cash cows, but diversifying with $ALNR feels right for steady growth.
0
Reply
User avatar and name identifying the post author
Bitter_Face8790
02/11
Avanquest ditched the dead weight, focusing on core biz. Smart move for better profitability.
0
Reply
User avatar and name identifying the post author
joe4942
02/11
Claranova's roadmap looks ambitious. €575-625M target by 2027? Let's see if they pull it off.
0
Reply
User avatar and name identifying the post author
tenebrium38
02/11
@joe4942 Think they'll hit the target?
0
Reply
User avatar and name identifying the post author
btcmoney420
02/11
Avanquest margins up, operating costs down. Core business focus is the way to go. 📈
0
Reply
User avatar and name identifying the post author
RamBamBooey
02/11
@btcmoney420 Avanquest strong move, but watch margins.
0
Reply
User avatar and name identifying the post author
QuantumQuicksilver
02/11
myDevices sale can't come soon enough, distractions gone.
0
Reply
User avatar and name identifying the post author
EX-FFguy
02/11
Avanquest trimming fat, margins looking better.
0
Reply
User avatar and name identifying the post author
Didntlikedefaultname
02/11
@EX-FFguy Fat trimmed, but myDevices still a drag.
0
Reply
User avatar and name identifying the post author
Silgro94
02/11
@EX-FFguy Avanquest cutting costs, margins up. Solid move.
0
Reply
User avatar and name identifying the post author
BenGrahamButler
02/11
PlanetArt's steady gains, bullish on synergies.
0
Reply
User avatar and name identifying the post author
NEYO8uw11qgD0J
02/11
@BenGrahamButler Synergies might boost PlanetArt, but watch margins.
0
Reply
User avatar and name identifying the post author
elpapadoctor
02/11
Canaccord Genuity handling myDevices sale. Hopefully, they get a sweet deal.
0
Reply
User avatar and name identifying the post author
GnosticSon
02/11
@elpapadoctor Fair enough
0
Reply
User avatar and name identifying the post author
Dosimetry4Ever
02/11
PlanetArt's stable revenue is a good base. Synergies will help, but market growth is where the real juice is. 🌳
0
Reply
User avatar and name identifying the post author
LackToesToddlerAnts
02/11
@Dosimetry4Ever What about Avanquest's growth potential?
0
Reply
User avatar and name identifying the post author
Aertypro
02/11
Holding $CLRN for long haul, potential 2x return.
0
Reply
User avatar and name identifying the post author
slumbering-gambit
02/11
PlanetArt's e-commerce game strong. Mobile and web both killing it. Keep an eye on those returns optimization efforts.
0
Reply
User avatar and name identifying the post author
TheOSU87
02/11
myDevices is toast. No synergy, so goodbye. Claranova focusing on what bleeds profit.
0
Reply
User avatar and name identifying the post author
tinyraccoon
02/11
myDevices sale could be a game-changer. No synergy drag, more focus for $CLRN. But hope they don't overpay for it.
0
Reply
User avatar and name identifying the post author
crentony
02/11
Security segment shines, keep eyes on $AVSQ.
0
Reply
User avatar and name identifying the post author
Bothurin
02/11
Holding some $ALNR for long term. Betting on their digital growth and cost control.
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App